Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IgA-specific serine endopeptidase (commonly known as IgA protease) is a bacterial enzyme secreted by several pathogenic organisms, including Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae. It selectively cleaves human immunoglobulin A subclass 1 (IgA1) in the proline-rich hinge region of its heavy chain, but does not affect IgA2. By degrading IgA1, a key antibody in mucosal immunity, the enzyme disrupts local immune defense, facilitating bacterial adherence and colonization of mucous membranes. This activity may play a central role in the virulence of these pathogens; however, the enzyme varies in specificity among species and there are no current small-molecule therapeutics directly targeting it
Bacterial IgA-specific serine endopeptidase cleaves IgA1 at Pro-|-Xaa bonds in the hinge region, abrogating the immunological function of IgA1 antibodies and weakening mucosal immunity, thus promoting bacterial survival and colonization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IgA-specific serine endopeptidase.